title: Viral pharmacovigilance study of haemophiliacs receiving porcine factor VIII.
abstract: Porcine factor VIII (FVIII; Hyate:C; Speywood Biopharm Ltd, UK) has been used since 1980 for the treatment both of patients with acquired haemophilia and those with congenital haemophilia and inhibitory antibodies. Each batch is extensively screened using cell-culture techniques to confirm the absence of viruses. The production process does not incorporate specific virucidal treatment steps, such as heat treatment or the addition of a solvent/detergent mixture. Low levels of porcine parvovirus were detected in some batches of the product in late 1996 and supply was suspended. In this retrospective study, sera from 81 recipients of porcine FVIII and 125 other volunteers were screened for evidence of antibodies against a range of porcine viruses: porcine parvovirus (PPV), encephalomyocarditis virus (EMCV), and porcine respiratory and reproductive syndrome virus (PRRSV). The 125 volunteer controls included subjects from six categories: healthy control subjects, pig abattoir personnel, personnel involved in the manufacture of porcine FVIII, recipients of porcine heparin, recipients of porcine insulin, and haemophiliacs treated only with human FVIII. No antibodies to PPV or PRRSV were detected in any subject. Four patients and two volunteers were found to have antibodies to EMCV, but this incidence is similar to that observed in the general population. In conclusion, there was no evidence of transmission of PPR or other marker porcine virus associated with the use of porcine FVIII concentrate (Hyate: C).
authors.affiliation: Oxford Haemophilia Centre and Thrombosis Unit, Churchill Hospital, Oxford, UK. paul.giangrande@ndm.ox.ac.uk
authors.forename: P L F
authors.initials: PL
authors.lastname: Giangrande
authors.forename: C M
authors.initials: CM
authors.lastname: Kessler
authors.forename: C E
authors.initials: CE
authors.lastname: Jenkins
authors.forename: P J
authors.initials: PJ
authors.lastname: Weatherill
authors.forename: P D
authors.initials: PD
authors.lastname: Webb
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D004340:Drug Contamination; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D008297:Male; D010321:Parvoviridae / Q000276:immunology / Q000302:isolation & purification*; D019316:Porcine respiratory and reproductive syndrome virus / Q000276:immunology / Q000302:isolation & purification; D012189:Retrospective Studies; D013552:Swine
chemical_list: D000914:Antibodies, Viral; D005169:Factor VIII